The Dexcom G7 rtCGM System
The most accurate glucose sensor available in Canada†,1, Dexcom G7 is proven to improve diabetes outcomes2-6, and is our easiest to use, most discreet CGM. Dexcom G7 measures glucose levels up to every 5 minutes, and sends readings wirelessly to a smart device‡ or optional receiver, giving people actionable glucose data – without the need for routine fingersticks* or scanning.
The most accurate rtCGM system*,1
Powering Confident Decisions
That Lead To Better Outcomes2-6
The most accurate
CGM system*,1
Associated with significantly better real-world glycemic outcomes vs. Freestyle Libre isCGM¶,8
Only Dexcom rtCGM has a predictive Urgent Low Soon alert9
Designed for all types of diabetes9
No routine finger pricks* or scanning
Painless, one-push auto-applicator
Less hypoglycemia1-6
More time in range1-6
Easier than ever to use – and to continue using††,11
Customizable alerts that work
for your patients
The Dexcom G7 app gives your patients the flexibility to customize
alert sounds and settings to best fit their lifestyle and needs.
Silence All
With this setting, all alerts will not sound or vibrate for up to 6 hours. Visual notifications will still appear on the lock screen.
Delay 1st Alert
It enables users to delay their first High alert until their sensor reading is high for a while, allowing them to make their glucose alerts work for them.
Quiet Mode
When this setting is enabled all Dexcom G7 alerts will vibrate. A users Urgent Low Glucose and Technical Alerts will still escalate to sound if not acknowledged.
Urgent Low Alert
Alerts a user when their sensor reading is at 3.1 mmol/L or below. This alert cannot be turned off or silenced.
Low Glucose Alert
Alerts the user when sensor readings is at or below the level set. A user customizes this setting to enable tighter control and help get ahead of lows.
Urgent Low Soon
Provides a 20-minute advance warning of when a user reaches 3.1 mmol/L so that they can act quickly and avoid a potential hypoglycemic event.
High Glucose Alert
Alerts you when sensor readings are at or above the set levels. It’s the yellow line on the trend graph.
Rising & Falling Fast Alerts
Let a user know when their sensor readings are changing quickly. They will see double arrows on your glucose reading. These alerts can be turned off in the Profile tab.
With a new all-in-one sensor, Dexcom G7 can be easily inserted with one push. After a 30-minute warm-up – the fastest of any CGM – people will be able to view real-time glucose data on a compatible smart device† or receiver. Plus, with a new 12-hour grace period, they can change their sensor when it’s more convenient.9
All-in-One Sensor
All-in-one sensor monitors interstitial glucose levels through a small wire inserted just underneath the skin, and sends glucose readings up to every 5 minutes wirelessly via Bluetooth to the wearer's display device†
(Length of sensor wear: 10 days + 12-hour grace period)
Display Devices
Allows people to view their real-time glucose data and trends, receive alerts and alarms, and other notifications on their compatible smart device† or receiver.
Our redesigned app allows people to easily see where their glucose levels are heading and how fast, keeping them engaged and motivated. It also offers greater customization, including a new Delay 1st Alert and the ability to silence all alerts when desired.9 Plus, the app now provides integration of Dexcom Clarity data, for better management decisions.//
With Dexcom Follow, people can share data with up to 10 followers – who can track their progress and offer support – for greater peace of mind.#,**,9
Footnotes
* When compared with CGM systems commercially available in Canada as of October 2023. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen.
† For a list of compatible devices, visit dexcom.com/compatibility.
‡ In people with type 1 diabetes using basal-bolus insulin therapy or CSII, or with impaired awareness of or recent severe hypoglycemia; and in people with type 2 diabetes using basal-bolus insulin therapy who have not achieved their A1C target.
§ Mean absolute relative difference (MARD) is a statistical measure of accuracy. The lower the number, the more accurate.
¶ Retrospective, real-world observational analysis of the Canadian LMC Diabetes Registry using the medical records of 143 consenting CGM-naïve adults with type 1 diabetes (T1D) in each rtCGM and isCGM matched cohorts. To be eligible, people must have had: diagnosis of T1D >12 months, baseline A1C >7.0%, and 1 or more completed HbA1c measurements 6 months prior and 6-12 months post-index date.
†† Based on data from Dexcom CGM users in the U.S.
// Healthcare providers will only be able to view a user’s glucose data if the user elects to share it with them through Dexcom Clarity.
# Followers must have compatible smart devices to use the Dexcom Follow app. To view a list of compatible devices, visit dexcom.com/compatibility.
** Separate Dexcom Follow app and internet connection required. Internet connectivity required for data sharing. Followers should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.
isCGM=intermittently scanned continuous glucose monitoring.
References
1. Dexcom, data on file, 2023.
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7. Cheng A, et al. Can J Diabetes 45 (2021) 580-587.
8. Brown RE, et al. Diabetic Medicine. 2022;39:e14937.
9. Dexcom G7 CGM System User Guide.
10. Freestyle Libre 2 Flash Glucose Monitoring System User’s Manual.
11. Dexcom, U.S. data on file, 2022.